JAMA Dermatology

DURHAM, N.C., Aug 26, 2026 Priovant Therapeutics announced the publication of skin-specific outcomes from the Phase 3 VALOR trial...

AUSTIN, Texas, July 22, 2026 Natera announced the publication of a prospective, multicenter study in JAMA Dermatology demonstrating that...